Institut de Cancérologie de l'Ouest;Université d'Angers;Institut National de la Santé et de la Recherche Médicale (INSERM)
发明人:
GUETTE, Catherine,CAMPONE, Mario,COQUERET, Olivier,BARRE, Benjamin
申请号：
EP20140802443
公开号：
EP3071972(B1)
申请日:
2014.11.24
申请国别(地区):
欧洲专利局
年份:
2018
代理人:
摘要：
The present invention is in the technical field of breast cancer management, and more particularly relates to the diagnosis and/or prognosing of triple-negative breast cancer (TNBC). The invention is more particularly based on the finding that specific biomarkers are abberantly expressed in patients suffering from a triple-negative breast cancer recurrence, and are highly related to the aggressiveness of this disease, and thus to survival of said patient.
